William Zinn, MD
To the Editors: Kaplan (1) failed to address in his recent review of the overtreatment of hypertension whether merely treating rather than controlling hypertension is adequate for the prevention of morbid events. In the Systolic Hypertension in the Elderly Program (SHEP) (2) and the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) study (3), a relatively fixed dosage schedule was used and a number of elderly patients who were treated did not reach their target blood pressure level (28% in the case of the SHEP study). The authors did not do subgroup analysis to determine whether patients who did not
Zinn W. Overtreating Hypertension. Ann Intern Med. ;117:536–537. doi: 10.7326/0003-4819-117-6-536
Download citation file:
Published: Ann Intern Med. 1992;117(6):536-537.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use